JP2009518397A - 高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー - Google Patents

高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー Download PDF

Info

Publication number
JP2009518397A
JP2009518397A JP2008544353A JP2008544353A JP2009518397A JP 2009518397 A JP2009518397 A JP 2009518397A JP 2008544353 A JP2008544353 A JP 2008544353A JP 2008544353 A JP2008544353 A JP 2008544353A JP 2009518397 A JP2009518397 A JP 2009518397A
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
compound
mmol
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008544353A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009518397A5 (https=
Inventor
ゲアリー エイチ ポズナー
イクヒョン パイク
クリスティナ ボストニック
ウォンスク チャン
サンドラ シニシュタイ
ウィリアム アンソニー マイオ
ジョン ガエタノ ダンジェロ
ローレン エレイン ウッダード
アルヴィン ソロマン カリンダ
エイミー アール ユセラ
リンゼイ キャサリン ヘス
アンドリュー スコット ローゼンタール
ソンホ オー
アシュトリート ツェー ベーゲ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Government of the United States of America
Original Assignee
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government of the United States of America filed Critical Government of the United States of America
Publication of JP2009518397A publication Critical patent/JP2009518397A/ja
Publication of JP2009518397A5 publication Critical patent/JP2009518397A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2008544353A 2005-12-08 2006-11-17 高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー Pending JP2009518397A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74854805P 2005-12-08 2005-12-08
US76512506P 2006-02-03 2006-02-03
US79481106P 2006-04-25 2006-04-25
PCT/US2006/044845 WO2007067333A2 (en) 2005-12-08 2006-11-17 Trioxane dimers having high anticancer and long-lasting antimalarial activities

Publications (2)

Publication Number Publication Date
JP2009518397A true JP2009518397A (ja) 2009-05-07
JP2009518397A5 JP2009518397A5 (https=) 2010-01-14

Family

ID=38123365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008544353A Pending JP2009518397A (ja) 2005-12-08 2006-11-17 高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー

Country Status (10)

Country Link
US (1) US20090291923A1 (https=)
EP (1) EP1962596A4 (https=)
JP (1) JP2009518397A (https=)
KR (1) KR20080081310A (https=)
AU (1) AU2006323040A1 (https=)
BR (1) BRPI0619759A2 (https=)
CA (1) CA2632200A1 (https=)
IL (1) IL191597A0 (https=)
MX (1) MX2008007358A (https=)
WO (1) WO2007067333A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2141499A1 (en) * 2008-07-02 2010-01-06 Apoptec AG COPD diagnosis
US8592611B2 (en) 2008-07-17 2013-11-26 The Johns Hopkins University Trioxane dimer sulfur compounds
WO2010032165A2 (en) * 2008-09-19 2010-03-25 North-West University Prodrugs of artemisinin
US8884032B2 (en) 2009-05-19 2014-11-11 The Johns Hopkins University Trioxane monomers and dimers
WO2011071947A2 (en) 2009-12-07 2011-06-16 Johns Hopkins University Bis-acylated hydroxylamine derivatives
US20110144067A1 (en) * 2009-12-07 2011-06-16 Toscano John P N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives
US9493480B2 (en) 2011-04-15 2016-11-15 The Johns Hopkins University Monomeric trioxane amide sulfur compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028476A2 (en) * 2002-09-27 2004-04-08 Johns Hopkins University Artemisinin-derived trioxane dimers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121749A0 (en) * 1997-09-11 1998-02-22 Yeda Res & Dev 2,3-dioxabicycloÚ3.3.1¾nonane derivatives and antimalarial pharmaceutical compositions comprising them
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
AU2003233509A1 (en) * 2002-05-07 2003-11-11 University Of Mississipi Artemisinin-based peroxide compounds as broad spectrum anti-infective agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028476A2 (en) * 2002-09-27 2004-04-08 Johns Hopkins University Artemisinin-derived trioxane dimers

Also Published As

Publication number Publication date
IL191597A0 (en) 2009-02-11
WO2007067333A2 (en) 2007-06-14
WO2007067333A3 (en) 2008-01-31
KR20080081310A (ko) 2008-09-09
AU2006323040A1 (en) 2007-06-14
EP1962596A2 (en) 2008-09-03
US20090291923A1 (en) 2009-11-26
EP1962596A4 (en) 2010-09-22
MX2008007358A (es) 2008-11-10
CA2632200A1 (en) 2007-06-14
BRPI0619759A2 (pt) 2011-10-18

Similar Documents

Publication Publication Date Title
US11459327B1 (en) Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof
JP2023508482A (ja) スピロ環含有キナゾリン化合物
WO2021027911A1 (zh) 新型螺环类K-Ras G12C抑制剂
EP2947086B1 (en) Novel fused pyrimidine compound or salt thereof
RS51226B (sr) Derivati azapeptida kao inhibitori hiv proteaze
JP2017039730A (ja) Hsp90関連病態の治療のために有用なポコキシム複合物
US20250195475A1 (en) Cdk2 inhibitor and preparation method and use thereof
WO2014116642A1 (en) Two-carbon linked artemisinin-derived trioxane dimers
US20250032623A1 (en) Heterobifunctional compounds and their use in treating disease
JP2009518397A (ja) 高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー
JP7475370B2 (ja) ブルトン型チロシンキナーゼ阻害剤としての置換されている1-アミノ-1h-イミダゾール-5-カルボキサミド
US20110257111A1 (en) Hydroxyethlamino Sulfonamide Derivatives
CN103304573A (zh) 石蒜碱类化合物在制备抗肿瘤药物的应用
CN101325874A (zh) 具有高抗癌活性和长效抗疟活性的三噁烷二聚物
EP1897871A1 (en) Benzenoid ansamycin derivative
JP6727231B2 (ja) 癌および糖尿病の治療に有用なエポキシアズレン誘導体
CA2749496A1 (en) Compositions and methods of use
CN111377854A (zh) Cxcr4抑制剂及其应用
EP4534542A1 (en) Thiosugar based isothiocyanates and uses thereof
CN103450164B (zh) 格尔德霉素衍生物及其制备方法和用途
AU2024308508A1 (en) Heterobifunctional compounds and methods of use thereof
EP4365175A1 (en) Novel benzopyran derivative and use thereof
WO2022191092A1 (ja) キノリン化合物、hnmt阻害剤、及びadhd、ナルコレプシー又はアルツハイマーの予防・治療剤
EA051754B1 (ru) Спироиндолиновые ингибиторы kif18a
CN115819189A (zh) 多酚类化合物及其制备方法和应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091117

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091117

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121105

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130401